InnerScope Hearing Technologies, Inc.
InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, and doctor-formulated dietary hearing supple… Read more
InnerScope Hearing Technologies, Inc. (INNDD) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, InnerScope Hearing Technologies, Inc. (INNDD) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
InnerScope Hearing Technologies, Inc. - Net Assets Trend (None–None)
This chart illustrates how InnerScope Hearing Technologies, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for InnerScope Hearing Technologies, Inc. (None–None)
The table below shows the annual net assets of InnerScope Hearing Technologies, Inc. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to InnerScope Hearing Technologies, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
InnerScope Hearing Technologies, Inc. Competitors by Market Cap
The table below lists competitors of InnerScope Hearing Technologies, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gammon Pakistan Ltd
KAR:GAMON
|
$492.50 |
|
Fidelity Special Values
LSE:FSV
|
$492.79 |
|
Dawood Equities Ltd
KAR:DEL
|
$493.45 |
|
Cannabis Poland S.A.
WAR:CBD
|
$493.66 |
|
SEQL3F
SA:SEQL3F
|
$491.62 |
|
PBT
WAR:PBT
|
$491.04 |
|
Impax Environmental Markets PLC
LSE:IEM
|
$490.50 |
|
United Insurance Company of Pakistan Ltd
KAR:UNIC
|
$490.48 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in InnerScope Hearing Technologies, Inc.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares InnerScope Hearing Technologies, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently InnerScope Hearing Technologies, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares InnerScope Hearing Technologies, Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| InnerScope Hearing Technologies, Inc. (INNDD) | $- | N/A | N/A | $492.45 |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |